0000316011-26-000003.txt : 20260108 0000316011-26-000003.hdr.sgml : 20260108 20260108160007 ACCESSION NUMBER: 0000316011-26-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260107 FILED AS OF DATE: 20260108 DATE AS OF CHANGE: 20260108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LILLY ENDOWMENT INC CENTRAL INDEX KEY: 0000316011 ORGANIZATION NAME: STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 26519543 BUSINESS ADDRESS: STREET 1: 2801 NORTH MERIDIAN STREET CITY: INDIANANAPOLIS STATE: IN ZIP: 46208 BUSINESS PHONE: 3179245471 MAIL ADDRESS: STREET 1: 2801 NORTH MERIDIAN ST CITY: INDIANAPOLIS STATE: IN ZIP: 46208 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ELI LILLY & Co CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 FORMER COMPANY: FORMER CONFORMED NAME: LILLY ELI & CO DATE OF NAME CHANGE: 19941024 4 1 form4-01082026_040101.xml X0508 4 2026-01-07 0000059478 ELI LILLY & Co LLY 0000316011 LILLY ENDOWMENT INC 2801 NORTH MERIDIAN STREET INDIANAPOLIS IN 46208-0068 false false true false 0 Common Stock 2026-01-07 4 S 0 895 1085.108 D 92188231 D Common Stock 2026-01-07 4 S 0 7684 1086.748 D 92180547 D Common Stock 2026-01-07 4 S 0 1070 1087.801 D 92179477 D Common Stock 2026-01-07 4 S 0 930 1088.967 D 92178547 D Common Stock 2026-01-07 4 S 0 3575 1090.183 D 92174972 D Common Stock 2026-01-07 4 S 0 1224 1091.048 D 92173748 D Common Stock 2026-01-07 4 S 0 1072 1092.557 D 92172676 D Common Stock 2026-01-07 4 S 0 1322 1093.584 D 92171354 D Common Stock 2026-01-07 4 S 0 420 1094.701 D 92170934 D Common Stock 2026-01-07 4 S 0 475 1095.738 D 92170459 D Common Stock 2026-01-07 4 S 0 6408 1097.412 D 92164051 D Common Stock 2026-01-07 4 S 0 9573 1098.552 D 92154478 D Common Stock 2026-01-07 4 S 0 20447 1099.361 D 92134031 D Common Stock 2026-01-07 4 S 0 14937 1100.459 D 92119094 D Common Stock 2026-01-07 4 S 0 20668 1101.423 D 92098426 D Common Stock 2026-01-07 4 S 0 34434 1102.411 D 92063992 D Common Stock 2026-01-07 4 S 0 40956 1103.313 D 92023036 D Common Stock 2026-01-07 4 S 0 21042 1104.403 D 92001994 D Common Stock 2026-01-07 4 S 0 24362 1105.456 D 91977632 D Common Stock 2026-01-07 4 S 0 13701 1106.416 D 91963931 D Common Stock 2026-01-07 4 S 0 16650 1107.371 D 91947281 D Common Stock 2026-01-07 4 S 0 13247 1108.415 D 91934034 D Common Stock 2026-01-07 4 S 0 8513 1109.318 D 91925521 D Common Stock 2026-01-07 4 S 0 3464 1110.367 D 91922057 D Common Stock 2026-01-07 4 S 0 2085 1111.214 D 91919972 D Common Stock 2026-01-07 4 S 0 4652 1112.433 D 91915320 D Common Stock 2026-01-07 4 S 0 9053 1113.771 D 91906267 D Common Stock 2026-01-07 4 S 0 4342 1114.372 D 91901925 D Common Stock 2026-01-07 4 S 0 2210 1115.761 D 91899715 D Common Stock 2026-01-07 4 S 0 2737 1116.686 D 91896978 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,085.00 to $1,085.60, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1), (2), (3), (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15), (16), (17), (18), (19), (20), (21), (22), (23), (24), (25), (26), (27), (28), (29), and (30) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,086.28 to $1,087.06, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,087.45 to $1,088.36, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,088.50 to $1,089.32, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,089.79 to $1,090.78, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,090.88 to $1,091.51, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,091.97 to $1,092.80, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,093.41 to $1,093.61, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,094.56 to $1,094.85, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,095.71 to $1,095.89, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,096.87 to $1,097.83, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,097.87 to $1,098.82, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,098.87 to $1,099.86, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,099.88 to $1,100.85, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,100.88 to $1,101.87, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,101.88 to $1,102.87, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,102.88 to $1,103.86, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,103.88 to $1,104.87, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,104.88 to $1,105.87, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,105.88 to $1,106.87, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,106.93 to $1,107.92, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,107.93 to $1,108.92, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,108.94 to $1,109.91, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,110.00 to $1,110.94, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,111.01 to $1,112.00, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,112.03 to $1,113.00, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,113.05 to $1,114.01, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,114.05 to $1,115.00, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,115.11 to $1,116.07, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1,116.15 to $1,117.11, inclusive. /s/ Peter A. Buck, Vice President for Investments and Grants Administration, on behalf of Lilly Endowment Inc. 2026-01-08